Understanding how deep brain stimulation affects decision-making in Parkinson's Disease
Official title: Cortical Electrophysiology of Response Inhibition in Parkinson's Disease
Run by Emory University · NCT06234995 · Data updated 2026-11-12
This study tests how deep brain stimulation affects decision-making and impulse control in people with Parkinson's Disease.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 45 Years to 75 Years |
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | Emory University Academic / other |
| Locations | 2 sites (Atlanta, Georgia and 1 other locations) |
| Status | Recruiting |
| Started | August 9, 2021 |
| Main results expected | September 2027 |
| Study ends | September 2027 |
| Registry record updated | September 3, 2026 |
| Trial ID | NCT06234995 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals diagnosed with idiopathic Parkinson's Disease who are in Hoehn and Yahr stages 2-4 and are eligible for DBS surgery.
✕Probably not a fit
Patients with severe tremor, dyskinesia, dementia, or other significant medical conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effects of deep brain stimulation (DBS) on executive functions in patients with Parkinson's Disease (PD). It examines how the location of stimulation and the size of the electrical field produced by DBS influence the brain circuits involved in response inhibition. Patients will be assessed before, during, and after the DBS implantation procedure to determine the impact on their ability to control impulsive actions. The research aims to shed light on the relationship between DBS and cognitive functions critical for daily decision-making.
Why it matters
Potential benefit: If successful, this study could lead to improved DBS techniques that enhance cognitive control and reduce impulsivity in patients with Parkinson's Disease.
How similar studies have gone: Other studies have explored the effects of DBS on motor functions, but this specific focus on executive function and response inhibition is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria for Persons with Parkinson's Disease for Aim 1: * diagnosis of idiopathic Parkinson's disease (PD) * Hoehn and Yahr (H\&Y) stage 2-4 (off medication) Exclusion Criteria for Persons with Parkinson's Disease for Aim 1: * severe tremor at rest or severe dyskinesia which would cause significant artifacts in electrophysiological signals * inability to hold antiparkinsonian medications for research recordings * dementia * non-English speaker Inclusion Criteria for Persons with Parkinson's Disease for Aim 2: * diagnosis of idiopathic PD * there is a clinical indication for DBS surgery * normal preoperative MRI * ability to tolerate microelectrode-guided neurosurgery in an awake state Exclusion Criteria for Persons with Parkinson's Disease for Aim 2: * presence of a coagulopathy * uncontrolled hypertension * heart disease * other medical conditions considered to increase the patient's risk for surgical complications Inclusion Criteria for Persons with Parkinson's Disease for Aim 3: * diagnosis of idiopathic PD * functioning DBS system Exclusion Criteria for Persons with Parkinson's Disease for Aim 3: * severe tremor at rest or severe dyskinesia which would cause significant artifacts in electrophysiological signals * inability to hold antiparkinsonian medications for research recordings * inability to tolerate temporary discontinuation of DBS therapy or alteration of stimulation settings for research purposes * other medical conditions considered to increase the patient's risk for surgical complications Inclusion Criteria for Healthy Controls: * age 45-75 Exclusion Criteria for Healthy Controls: * history of a neuropsychiatric disorder and/or treatment with psychotropic medications * non-English speaker
Where it's running
-
Emory University Hospital
Atlanta, Georgia, United States Recruiting -
Emory Brain Health Center
Atlanta, Georgia, United States Recruiting
Study contacts
- Principal investigator: Svjetlana Miocinovic, MD, PhD — Emory University
- Study coordinator: Jonna Seppa
- Email: jonna.k.seppa@emory.edu
- Phone: 404-727-1509
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions
A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.
-
Tributyrin for PSP: a virtual, early-phase study
This study tests whether tributyrin is safe and tolerable in people with Progressive Supranuclear Palsy who are 45 or older, using virtual visits.
-
A look at why Lewy body conditions cause visual hallucinations
This study tests brain‑imaging in people with Lewy body diseases who do or don’t experience visual hallucinations, and in healthy volunteers, to see how brain networks might create these images.
-
How physical activity might help people with Parkinson’s disease who have DBS-STN implants
This study tests whether adding regular physical activity can help people with Parkinson’s who have DBS-STN stimulation by trying a structured physiotherapy approach alongside standard care.
-
Can hippotherapy improve mobility, gait, balance, and quality of life in people with Parkinson's disease?
This pilot trial tests whether adding horse-assisted therapy to standard rehab helps mobility, gait, balance, and perceived health in adults with Parkinson's disease.
-
Gut methane and Parkinson's: measuring if a probiotic helps people with Parkinson's, REM sleep behavior disorder, or cognitive concerns
This study tests whether a probiotic containing Limosilactobacillus reuteri can help people with Parkinson's disease, those at high risk for PD, and related cognitive issues by potentially improving gut methane levels and overall symptoms.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.